SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-23-037934
Filing Date
2023-08-03
Accepted
2023-08-03 16:03:46
Documents
69
Period of Report
2023-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q aldx-20230630.htm   iXBRL 10-Q 2365478
2 EX-10.1 aldx-ex10_1.htm EX-10.1 364505
3 EX-31.1 aldx-ex31_1.htm EX-31.1 20897
4 EX-31.2 aldx-ex31_2.htm EX-31.2 21314
5 EX-32.1 aldx-ex32_1.htm EX-32.1 16076
6 GRAPHIC img129964144_0.jpg GRAPHIC 92546
  Complete submission text file 0000950170-23-037934.txt   8163266

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT aldx-20230630_def.xml EX-101.DEF 150730
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT aldx-20230630_pre.xml EX-101.PRE 275507
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT aldx-20230630_cal.xml EX-101.CAL 41320
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT aldx-20230630_lab.xml EX-101.LAB 388366
11 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT aldx-20230630.xsd EX-101.SCH 47675
63 EXTRACTED XBRL INSTANCE DOCUMENT aldx-20230630_htm.xml XML 1208526
Mailing Address 131 HARTWELL AVENUE SUITE 320 LEXINGTON MA 02421
Business Address 131 HARTWELL AVENUE SUITE 320 LEXINGTON MA 02421 781-761-4904
Aldeyra Therapeutics, Inc. (Filer) CIK: 0001341235 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36332 | Film No.: 231139798
SIC: 2834 Pharmaceutical Preparations